Balyasny Asset Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Balyasny Asset Management’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,000	Closed	-$2.58M	–	3236
2022 Q4	$2.58M	Hold	5,000	–	–	0.01%	1299
2022 Q3	$2.54M	Hold	5,000	–	–	0.01%	1359
2022 Q2	$2.5M	Hold	5,000	–	–	0.01%	1282
2022 Q1	$2.5M	Buy	+5,000	New	+$2.49M	0.01%	1268

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management's TVGN Position: Q1 2023 in Review

Balyasny Asset Management sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 5,000 shares — an estimated $2.58M sold.

Balyasny Asset Management first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $2.58M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Balyasny Asset Management reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Balyasny Asset Management sold 5,000 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $2.58M.
Balyasny Asset Management first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Balyasny Asset Management's Tevogen Inc. Common Stock position peaked at $2.58M in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.